Adjusts antiretroviral dosing for renal impairment (tenofovir alafenamide vs TDF), hepatic impairment (atazanavir/darunavir modification), and drug interaction screening for CYP3A4/P-glycoprotein interactions.
Enter the values for the scenario you are assessing. Adjusts antiretroviral dosing for renal impairment (tenofovir alafenamide vs TDF), hepatic impairment (atazanavir/darunavir modification), and drug interaction screening for CYP3A4/P-glycoprotein interactions. Use the art dose adjustment result to inform your calculation.